COVID 19 and behavioural science
The recent coronavirus outbreak is a clear concern for everyone. What has been interesting to me is how front and centre behavioural science has been in the government’s response to the ongoing crisis. In listening to the Prime Minister in his address to the UK nation on Monday it was noteworthy in his statements how, when he references the role of science in guiding their approach, he explicitly talked as much about behavioural science as he did about the science behind the disease.
Top 10 tips for conducting effective UX research
Creating a new digital asset? Make sure you do your research first. Different stakeholders, whether they are healthcare professionals, consumers, patients or caregivers, exhibit different behaviours and needs online. Ensure your asset offers the optimum user experience by following our 10 top tips for conducting effective UX research
Living with rheumatoid arthritis: How social stigma, unemployment and the rise of mental illness affects patient attitudes toward their disease in Japan
Rachel Arthurs explores differing social attitudes towards RA between patients living in Japan and patients in Europe and Canada.
In recent months, Research Partnership’s Mariel Metcalfe alongside her Living With team have been conducting an in-depth multi-country study into the experiences of those living with rheumatoid arthritis. The study was carried out amongst patients in Europe, Canada and Japan to gain insights into the ways in which patients react to their diagnosis, manage their treatment and the possible support they hope to see in the future. An interesting trend that emerged during the course of the research was the differing social attitudes towards illness between patients living in Japan compared to those in Europe and Canada. Japanese patient’s daily lives are impacted differently to those in other countries, possibly due to pre-existing stigmas and social attitudes. In this article, we examine these differences, consider why they might occur and propose how we can use this understanding to improve global treatment solutions and marketing of existing and pipeline pharmaceuticals.
Emotional Recognition using Facial Analysis
Do you have a poker face or does your expression give you away? According to psychologists, a lot of emotional information can be drawn from our facial expressions, which is valuable to us as market researchers as we are interested in the emotional responses driving people’s attitudes and behaviours. We recently partnered with a tech company called Affectiva which has analysed over 5 million faces and 24,000 adverts to understand how people respond to digital stimulus such as advertising, websites and apps. Our client wanted to understand physicians’ response to communications materials designed for a disease awareness campaign, so their technology was ideal for the project’s objective.
The value of design thinking: Incorporating creative and graphic design into pharma market research
How do we keep research design fresh and interesting? How do we ensure that we’re inspiring our respondents to give us enlightening new insights, and encourage new ways of thinking?
There is a strong precedent for incorporating ‘design thinking’ into methods for improving aspects of healthcare delivery, particularly now that there is a greater emphasis on patient centricity and improving the customer experience. A great story of design in product development comes from Doug Dietz, a principle designer for GE Healthcare. After spending two years designing a new MRI scanner, he was excited to see it in action. But at the hospital, as he observed a young family with a child approaching, he realised that the child was terrified.